REVOLUTIONISING
WOUND CARE

SolasCure’s mission is to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds.

Aurase Wound Gel aims to be a breakthrough in wound bed preparation for patients with chronic wounds

Every year ~85 million people suffer from chronic wounds worldwide

Patient-Focused
Biomimicry
Evidence-Based Medicine
RODUCT DESCRIPTION

Aurase Wound Gel, a hydrogel containing the proteolytic enzyme Tarumase, aims to facilitate debridement, reduce bacterial biofilm, and promote wound bed preparation and healing.

Tarumase is a recombinantly produced version of the key protease deployed by larvae in wounds to break down necrotic tissue.
A product of evolution, Tarumase is highly effective and does not provoke allergenic responses unlike many other proteases.

experience excellence

Lily is a trained biologist and has led global

Aurase is meant to ease the management of chronic wound processes for hospitals, nursing homes or homecare. Through biomimicry, Aurase illustrates the enormous and still largely untapped potential of biodiversity.
Passion is what drives us

SolasCure aims to support healthcare professionals with wound care products

Testimonials
Curious about what people say about us & our services?
SolasCure has assembled an experienced,
world-class team
Let's discuss now
Get in touch with us
We respond within 48 hours

We answer all email and requests as they come in. If you have an urgent matter or would like to place an order please click the link below to give us a call.